November is Diabetes Month in the United States, making this the perfect time to highlight the many resources and initiatives the Society dedicates to this chronic disease state.
Diabetes has always been a central feature of the Society’s work.
The discovery of insulin therapies just over 100 years ago transformed our field. And today, many of our members dedicate their clinical and research careers to finding new ways of treating diabetes.
That’s why I’m delighted to note the Society last month launched the Diabetes Special Interest Group (SIG), essentially creating a professional home for thousands of diabetes clinicians and scientists around the world.
The Diabetes SIG will connect endocrinologists, researchers, educators, and trainees who are committed to advancing diabetes research, prevention, and patient care.
And like our other SIGs, this one will provide many opportunities throughout the year for members to engage and collaborate. This is done through regularly scheduled webinars, as well as informal discussions on the EndoForum platform. Diabetes SIG members will share knowledge, discuss emerging developments, build professional networks, and explore innovations that improve outcomes for people living with diabetes. Always open, the SIG allows members to ask peers for advice or share thoughts at any time and from any location
Educational Programs and Activities
As important as this new SIG is, it’s only a small part of what the Society does in the realm of diabetes. Our organization offers a full spectrum of metabolism resources and initiatives. Below are some of them.
Many of the Society’s educational programs and meetings focus on diabetes. Recordings will soon be available from the recently concluded Clinical Endocrinology Update (CEU) 2026, which provided eight sessions on the topic:
- Managing Endocrine Complications of Immune Checkpoint Inhibitors: A Multidisciplinary Approach
- Diabetes in Pregnancy: Optimizing Maternal and Fetal Outcomes
- Once-Weekly Insulin: Innovations for Less Intervention in Diabetes
- Balancing for Two: Evidence-Based Care for Diabetes in Pregnancy
- Challenges and Opportunities for Understanding the Pathogenesis of Type 1 Diabetes: An Endocrine Society Scientific Statement
- Peripheral Vascular Disease in Diabetes: Screening, Prevention, and Management
- Intermittent Fasting in Diabetes: Science, Technology, and Patient-Centered Care
- Diabetes Technology in Practice: Insulin Pumps, CGMs, and Complex Case Management
Diabetes also is the topic of our upcoming joint meeting with Keystone: “Reimagining Diabetes: From Molecular Mechanisms to Transformative Therapies,” February 1 – 4, 2027, in Keystone, Colo. The meeting is designed to connect basic science, clinical research, and industry to better understand disease drivers and identify new therapeutic strategies.
Another exciting educational offering is the competitive Type 1 Diabetes Fellows Series. In 2026, the program marked its 13th year providing support to endocrine fellows as they begin their careers as practicing clinicians and diabetes experts.
No matter what aspect of diabetes and metabolism inspires you, we have the resources you need to expand your knowledge and grow your career. I am proud of all the work our members are doing to care for people with diabetes and study this condition.
During the June program at ENDO 2026 in Chicago, Ill., Camille Powe, MD, presented a session on how pregnant women with type 1 diabetes are still considered to have high-risk pregnancies, and susceptible to complications such as fetal overgrowth. Powe’s research was the subject of an Endocrine News podcast.
Check back on the fellows webpage for the 2027 application cycle.
I’m also pleased to announce the Society will debut a new lecture at ENDO 2027 named in honor of Jesse Roth, MD. Dr. Roth was a trailblazing endocrinologist whose research on insulin receptors revolutionized our understanding of diabetes. The Jesse Roth Award Lecture will feature a speaker who has made significant clinical and research contributions to endocrinology.
The Society provides even more diabetes education online through its Center for Learning. Offerings include conference session recordings on diabetes, as well as stand-alone events such as, Using Diabetes Technology in Pregnancy, and Two Generations, One Challenge: Confronting Obesity in Pregnancy and Childhood’s Metabolic Outcomes .
Diabetes also is an ever-present topic in our written educational resources. TheEndocrine Self-Assessment Program (ESAP) 2026 dedicated 30 cases to diabetes. Endocrine Board Review (EBR) 2026 provided another 52 cases. And the Meet the Professor (MTP) 2026 book included six chapters on diabetes:
- Updates in the Management of Diabetic Kidney Disease
- Type 2 Diabetes in Preconception, Pregnancy, and Postpartum
- Transition of Care in Patients with Youth-Onset Type 2 Diabetes
- Use of Adjunctive Glucose-Lowering Therapies to Target Cardiometabolic Risk in Type 1 Diabetes
- Managing Hyperglycemia in Hospitalized Patients
- GLP-1 Receptor Agonists and Pancreatitis and Pancreatic Lesions: What Is the Evidence and When Are They Contraindicated?
Our Endocrine Education Cases Flashcards include 57 cards on diabetes treatment in a convenient pocket guide for residents, fellows, and clinicians in training.
Diabetes Science and Research
Diabetes researchers have long found a welcome publishing home in our suite of scientific journals. The Society’s top Altmetric-scoring journal papers published so far in 2026 with “diabetes” as a keyword include:
- GLP-1 receptor agonists and the risk of fragility fractures in older adults with type 2 diabetes
- Greater reduction in the proinsulin-C-peptide ratio with a ketogenic vs control diet in patients with type 2 diabetes
- Social inequalities in gestational diabetes prevalence and complication burden: a nationwide Swedish cohort study
- The use of semaglutide as an add-on therapy in patients with latent autoimmune diabetes in adults
- Association between worsening time in range and microvascular complications in type 1 diabetes: real-world 5-year study.
These are the kinds of articles that our journals team gathers for a special thematic issue each year. This year’s April thematic issue, which includes articles from all of our journals, was dedicated to Obesity and Metabolic Health: Diet, Exercise, and Appetite Regulation.
Diabetes Advocacy
Another area where we excel on the diabetes front is advocacy. On Capitol Hill, we are one of the leading voices working to ensure that people living with diabetes have access to affordable insulin.
Our sustained efforts in years past have helped pass legislation to lower the cost of insulin for Medicare beneficiaries, and we currently are advocating to lower insulin cost for those on private insurance and the uninsured.
In addition, we’re advocating for Congress to reauthorize the Special Diabetes Program (SDP), a vital program that funds type 1 diabetes research and type 2 diabetes education and treatment programs for American Indians and Alaskan Native communities.
Another area where we excel on the diabetes front is advocacy. On Capitol Hill, we are one of the leading voices working to ensure that people living with diabetes have access to affordable insulin.
In October, our advocacy team launched its Diabetes Advocacy Campaign, to focus on reauthorizing SDP and passing the INSULIN Act.
Finally, we can’t help but have a little fun with this topic. Our store is full of products that allow our members to proudly display their diabetes bona fides. These include our pancreas socks, keychains, lapel pins, and plushies.
No matter what aspect of diabetes and metabolism inspires you, we have the resources you need to expand your knowledge and grow your career. I am proud of all the work our members are doing to care for people with diabetes and study this condition.
